BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34992074)

  • 1. Usefulness of Human Jejunal Spheroid-Derived Differentiated Intestinal Epithelial Cells for the Prediction of Intestinal Drug Absorption in Humans.
    Michiba K; Maeda K; Shimomura O; Miyazaki Y; Hashimoto S; Oda T; Kusuhara H
    Drug Metab Dispos; 2022 Mar; 50(3):204-213. PubMed ID: 34992074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.
    Inui T; Uraya Y; Yokota J; Yamashita T; Kawai K; Okada K; Ueyama-Toba Y; Mizuguchi H
    Stem Cell Res Ther; 2024 Feb; 15(1):57. PubMed ID: 38424603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum.
    Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H
    Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells].
    Iwao T
    Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Prediction of Intestinal Absorption of Drugs from In Vitro Study: Utilization of Differentiated Intestinal Epithelial Cells Derived from Intestinal Stem Cells at Crypts.
    Maeda K
    Drug Metab Dispos; 2023 Sep; 51(9):1136-1144. PubMed ID: 37142427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Hepatic and Intestinal Efflux Transport of Statins.
    Deng F; Tuomi SK; Neuvonen M; Hirvensalo P; Kulju S; Wenzel C; Oswald S; Filppula AM; Niemi M
    Drug Metab Dispos; 2021 Sep; 49(9):750-759. PubMed ID: 34162690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
    Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
    Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Breast Cancer Resistance Protein (BCRP/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers.
    Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
    Drug Metab Dispos; 2020 Jun; 48(6):491-498. PubMed ID: 32193356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Gene Expression Profile of Human Intestinal Epithelial Cells: From the Viewpoint of Drug Metabolism and Pharmacokinetics.
    Takayama K; Ito K; Matsui A; Yamashita T; Kawakami K; Hirayama D; Kishimoto W; Nakase H; Mizuguchi H
    Drug Metab Dispos; 2021 Mar; 49(3):221-232. PubMed ID: 33384384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
    Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
    J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of nutrient and electrolyte absorption in human organoid-derived intestinal epithelial cell monolayers.
    Haynes J; Palaniappan B; Tsopmegha E; Sundaram U
    Transl Res; 2022 Oct; 248():22-35. PubMed ID: 35513245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum.
    Gravel S; Panzini B; Belanger F; Turgeon J; Michaud V
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells.
    Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T
    Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinacanthin-C Mediated Herb-Drug Interactions with Drug Transporters and Phase I Drug-Metabolizing Enzymes.
    Dunkoksung W; Vardhanabhuti N; Siripong P; Jianmongkol S
    Drug Metab Dispos; 2019 Oct; 47(10):1040-1049. PubMed ID: 31399508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans.
    Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
    Drug Metab Dispos; 2014 Nov; 42(11):1947-54. PubMed ID: 25200868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters.
    Gopaul VS; Vildhede A; Andersson TB; Erlandsson F; Lee CA; Johansson S; Hilgendorf C
    J Pharmacol Exp Ther; 2021 Aug; 378(2):108-123. PubMed ID: 34074714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.